Effective as of January 1, 2023, Kiora Pharmaceuticals, Inc. moved its corporate headquarters to 332 Encinitas Boulevard, Suite 102, Encinitas, California 92024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | +1.20% |
|
+12.90% | -10.67% |
25/06 | Kiora Pharmaceuticals Appoints Roger A. Goldberg to its Scientific Advisory Board | CI |
10/05 | Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.67% | 12.48M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- EYEG Stock
- News Kiora Pharmaceuticals, Inc.
- Kiora Pharmaceuticals, Inc Moves Its Corporate Headquarters